A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01674348
Recruitment Status : Terminated (Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.)
First Posted : August 28, 2012
Last Update Posted : August 5, 2013
Information provided by (Responsible Party):
Piramal Enterprises Limited

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : July 2013